Jack Meehan; Analyst; Nephron Research Erin Wright; Analyst; Morgan Stanley ...

Q4 2024 Earnings Call Transcript January 30, 2025 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is ...

During Q4 2024, global stocks were pressured by investor concerns about economic growth and persistent inflation in some regions & despite potential for further interest rate cuts in 2025.

Welcome to the Quest Diagnostics Fourth Quarter and Full-Year 2024 Conference Call ... as we expand access through our health plan partnerships with Elevance Health and Sentara Health Plans ...

Elevance Health (ELV) Q4 CY2024 Highlights: Revenue: $45.44 billion vs analyst estimates of $45.34 billion (6.6% year-on-year growth, in line) Adjusted EPS: $3.84 vs analyst expectations of $3.85 ...

Equities research analysts at Zacks Research lowered their Q2 2025 earnings estimates for Elevance Health in a research ...

Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per ...

Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per share was ...

INDIANAPOLIS (AP) — INDIANAPOLIS (AP) — Elevance Health Inc. (ELV) on Thursday reported fourth-quarter net income of $418 million. The Indianapolis-based company said it had net income of $1. ...

Reports Q4 revenue $2.39B, consensus $2.47B. “Oscar reported positive full year 2024 results, capping the strongest year of financial ...

Mizuho Securities analyst Ann Hynes has maintained their bullish stance on DGX stock, giving a Buy rating yesterday.Invest with Confidence: ...